Christopher Bunick, MD, PhD, offered pointers on how to address the physical and mental aspects of this complex disease in this exclusive interview in conjunction with the American Academy of Dermatology 2022 Annual Meeting.

In this first part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, explains the science behind her presentation on "The Utility of Circulating Tumor DNA for Detecting Clinically Evident and Occult Merkel Cell Carcinoma." This was presented at the 2022 American Academy of Dermatology Annual Meeting.

In this week’s Pointers with Dr Portela, the 208SkinDoc answers the question, “Should I be taking a collagen supplement?” He breaks down the evidence as the answer is not as simple as it may seem.

In this video interview, Peter A. Lio, MD, FAAD , discusses his presentation about pain-free dermatology at the 2022 American Academy of Dermatology annual meeting. We talk strategies, benefits, and more.

In this video interview, Adam J. Friedman, MD, FAAD, gives the highlights from his presentation at the 2022 American Academy of Dermatology annual meeting about dietary triggers in acne, providing evidence, and discussing how the idea came to be.

In this video interview, we sit down with both Jennifer Lin Hsiao, MD, FAAD, and Scott Worswick, MD, FAAD, to talk in detail about their presentation, "Hidradenitis Suppurativa and Pityriasis Rubra Pilaris: Updates on Treatments for Two Conditions that are Difficult to Manage."

In this video interview, Christopher Bunick, MD, PhD dives into the topic of congenital ichthyosis describing his talk on the skin condition at the American Academy of Dermatology 2022 Annual Meeting.

Christopher Bunick, MD, PhD, talked about his presentation at the 2022 American Academy of Dermatology Annual Meeting on acne, which included a review of updated information on acne and practice pearls.

In this video interview, we sit down with Natasha Atanaskova Mesinkovska, MD, PhD, FAAD, to discuss her 2022 AAD annual meeting presentation on alopecia areata. We dive into pipeline possibilities, what current treatments are missing, and more.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses how treatments are often too expensive for patients, which causes them to be labeled as “non-compliant.” He discusses ways to improve adherence for both patients and doctors

An expert dermatologist evaluates the role of dupilumab in decreasing the clinical burden of severe atopic dermatitis on patients and their caregivers and shares insight on the future outlook of dupilumab in disease management.

Benjamin Lockshin, MD, FAAD, reviews key findings from a phase 2 trial evaluating the safety and efficacy of single-dose dupilumab in children with severe atopic dermatitis.

Benjamin Lockshin, MD, FAAD, comments on the significance of recent expansions of therapeutics options for patients with atopic dermatitis and unmet needs in the field.

Panelists share parting advice and key takeaways on the optimal management of atopic dermatitis within the treatment landscape.

Experts share insight on the challenges inherent in treating patients with atopic dermatitis despite recent advances in therapy.

In this video the OJM group talks about volatile markets and how to navigate investing in uncertain times.

Concluding their focused discussion on JAK inhibitors in atopic dermatitis, panelists share advice on the optimal selection based on route of administration and use of these agents.

In this week’s Pointers with Dr Portela, the 208SkinDoc interviews Jen Hamilton, a TikTok creator who recently made the decision to go the dermatologist to talk about tackling her acne.